Clinical Trials Logo

Filter by:
NCT ID: NCT04833829 Active, not recruiting - HIV Infections Clinical Trials

Cross-disciplinary HIV Integrated Mental Health Support Intervention

CHIMES
Start date: November 1, 2020
Phase: N/A
Study type: Interventional

The proposed project seeks to develop and test an intervention to improve engagement in HIV and mental health care for young Black gay, bisexual and other men who have sex with men (YB-GBMSM) in Ryan White clinics.

NCT ID: NCT04833582 Active, not recruiting - Osteosarcoma Clinical Trials

A Study of ZN-c3 in Combination With Gemcitabine in Subjects With Osteosarcoma

Start date: August 1, 2021
Phase: Phase 1/Phase 2
Study type: Interventional

This is a phase 1/2 study of ZN-c3 in combination with gemcitabine in adult and pediatric subjects with relapsed or refractory osteosarcoma.

NCT ID: NCT04833010 Active, not recruiting - Covid19 Clinical Trials

Effects of Face Masks During Exercise

Start date: January 20, 2021
Phase: N/A
Study type: Interventional

To describe the primary and secondary outcomes of athletes during a Cardiopulmonary Exercise Test (CPET) on a cycle ergometer with and without a face mask.

NCT ID: NCT04832971 Active, not recruiting - Mixed Dyslipidemia Clinical Trials

Study of ARO-ANG3 in Adults With Mixed Dyslipidemia

ARCHES-2
Start date: June 28, 2021
Phase: Phase 2
Study type: Interventional

The purpose of AROANG3-2001 is to evaluate the efficacy and safety of ARO-ANG3 in participants with mixed dyslipidemia. Participants will initially receive 2 subcutaneous injections of ARO-ANG3 or placebo. Participants who complete the double-blind treatment period may opt to continue in an open-label extension during which they will receive up to 8 doses of ARO-ANG3.

NCT ID: NCT04832932 Active, not recruiting - COVID-19 Vaccines Clinical Trials

The COVID-19 Back-to-Normal Study: Analysis of Multiple Outcomes

Start date: January 5, 2021
Phase:
Study type: Observational

During the study, members of different online and offline communities will be followed post COVID-19 vaccination. Injection-site (local) and systemic reaction data will be assessed on vaccination day and afterwards using either web surveys or personal communication, depending on study participant preference. Hypothesis to be tested: The safety profile and the magnitude and durability of immune responses to the COVID-19 vaccines as well as adverse reactions depend on health conditions, metabolism and microbiomes.

NCT ID: NCT04832919 Active, not recruiting - COVID-19 Clinical Trials

A Nurse-Community Health Worker-Family Partnership Model: Addressing Uptake of COVID-19 Testing and Control Measures

Start date: July 23, 2021
Phase: N/A
Study type: Interventional

Historically, health disparities in the US are concentrated among underserved communities and socially vulnerable populations. The disproportionate COVID-19 related morbidity and mortality in communities of color and socioeconomic disadvantage acutely highlight this persistent public health problem, drawing attention to the urgent need for more equitable reach of testing, prevention, and control measures. The proposed research addresses this need using a 2-arm randomized controlled trial (RCT) that will evaluate the effectiveness of the Nurse-Community Health Worker (CHW)-Family Partnership intervention in promoting COVID-19 testing uptake, adoption of COVID control measures, and mutual aid capacity at the household level in an underserved and vulnerable population disproportionately affected by COVID-19. Enrolled households will be randomly assigned to either the intervention group where families will receive the Nurse-CHW-Family Partnership intervention including the offer of in-home testing and referral to seasonal influenza vaccination services, or the treatment-as-usual control group, which will be used to measure actual testing rates among public housing residents in relation to participant and household characteristics. The study hypothesis is that the Nurse-CHW-Family Partnership intervention will improve household-level COVID-19 testing uptake, adoption of COVID control measures, and mutual aid capacity relative to the treatment-as-usual control.

NCT ID: NCT04832854 Active, not recruiting - Clinical trials for Non-Small Cell Lung Cancer (NSCLC)

A Study Evaluating the Safety and Efficacy of Neoadjuvant and Adjuvant Tiragolumab Plus Atezolizumab, With or Without Platinum-Based Chemotherapy, in Participants With Previously Untreated Locally Advanced Resectable Stage II, IIIA, or Select IIIB Non-Small Cell Lung Cancer

Start date: April 23, 2021
Phase: Phase 2
Study type: Interventional

This study will evaluate the surgical safety and feasibility of atezolizumab plus tiragolumab alone or in combination with platinum-based chemotherapy as neoadjuvant treatment for participants with previously untreated locally advanced non-small cell lung cancer (NSCLC). The study will also evaluate the efficacy, pharmacokinetics, immunogenicity, and safety of atezolizumab plus tiragolumab alone or in combination with platinum-based chemotherapy as neoadjuvant treatment, followed by adjuvant atezolizumab plus tiragolumab or adjuvant platinum-based chemotherapy.

NCT ID: NCT04832815 Active, not recruiting - PTSD Clinical Trials

Equine Human Interaction With Veterans

Start date: December 19, 2019
Phase: N/A
Study type: Interventional

This study has two components. The first component (Aim 1) is a randomized trial of a novel equine therapy intervention that was developed for research purposes. The second component (Aim 2) is an evaluation of outcomes from Veterans participating in an adaptive horsemanship program that is not conducted for research purposes.

NCT ID: NCT04832685 Active, not recruiting - Depression Clinical Trials

Neuromodulation of Mind-Wandering in Depression

Start date: March 20, 2023
Phase: N/A
Study type: Interventional

The specific aim of this proposed study is to investigate the feasibility and therapeutic potential of LIFUP in changing negative cognition in depression. Specifically, the investigators will study if modulating DMN activity can change maladaptive mind-wandering. The investigators hypothesize that DOWN-modulation of the posterior cingulate cortex (PCC), a key DMN node, will decrease DMN resting state functional connectivity, perfusion, and activation during a cognitive-affective task (description below). The investigators also hypothesize that DOWN-modulation of the PCC will be associated with decreased mind-wandering and increased mindfulness. Finally, the investigators hypothesize that the opposite will be true for UP-modulation of the PCC.

NCT ID: NCT04831372 Active, not recruiting - Osteoarthritis, Hip Clinical Trials

On-Table Versus Off-Table Total Hip Arthroplasty

Start date: April 7, 2021
Phase: N/A
Study type: Interventional

The Direct Anterior Approach (DAA) is a common way to perform total hip arthroplasty. There are two main techniques to perform total hip replacement through the anterior approach. The first method is the "on-table" method, which uses a specialized surgical table, called a traction table. This table involves placing both feet in specialized boots that are then hooked up to the table, and allows for positioning of the operative leg with aid of the table. The major limitations associated with the traction table are the need for two additional staff members and the purchase of said table. The second method is the "off-table" method. In this method the patient is placed on a standard operating room table and the operative leg is manually positioned by the surgeon during the procedure . This obviates the need for the additional staff members or purchase of a specialized table. Both the "on-table" and "off-table" techniques are routinely used both worldwide and by our joint replacement specialists at Carilion Clinic. This study will aim to compare the efficiency and efficacy of performing the DAA for total hip arthroplasty utilizing either the "on-table" or "off- table" technique. Patients will be randomized to receive their total hip arthroplasty with either the "on- table" or "off-table" method.